PT  - JOURNAL ARTICLE
AU  - Mehta, Arpan R
AU  - Kennard, Christopher
TI  - The pharmacological treatment of acquired nystagmus
AID  - 10.1136/practneurol-2011-000181
DP  - 2012 Jun 01
TA  - Practical Neurology
PG  - 147--153
VI  - 12
IP  - 3
4099  - http://pn.bmj.com/content/12/3/147.short
4100  - http://pn.bmj.com/content/12/3/147.full
SO  - Pract Neurol2012 Jun 01; 12
AB  - We review the latest literature on the neuropharmacological treatments for acquired nystagmus. Nystagmus may have a significantly impact on health, yet there is little scientific evidence on which to make firm recommendations for treatment. Acquired pendular nystagmus may respond to gabapentin or memantine; downbeat and upbeat nystagmus to aminopyridines; and periodic alternating nystagmus to baclofen. To improve treatment we need multi-centre, randomised controlled trials using standardised techniques in reporting objective outcomes, with good follow-up duration and careful reporting of side effects.